Georgetown Lombardi Comprehsnive Cancer Center — Washington D.C., District of Columbia

Georgetown Lombardi Comprehsnive Cancer Center is a clinical research site located in Washington D.C., District of Columbia, United States 20007.

Crixeo Health Trust Score: 41/100 (POOR). This profile has not yet been claimed by the site owner.

Georgetown Lombardi Comprehsnive Cancer Center has participated in 1 clinical trials.

Therapeutic areas: Melanoma.

Sponsors: Georgetown University.

Sponsor Feasibility Report

Trust Score: 41/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Georgetown Lombardi Comprehsnive Cancer Center?

Georgetown Lombardi Comprehsnive Cancer Center has a Crixeo Trust Score of 41/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Georgetown Lombardi Comprehsnive Cancer Center conducted?

Georgetown Lombardi Comprehsnive Cancer Center has 1 clinical trials on record. Their work covers Melanoma.

Is Georgetown Lombardi Comprehsnive Cancer Center accredited by Crixeo Health?

Georgetown Lombardi Comprehsnive Cancer Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Georgetown Lombardi Comprehsnive Cancer Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.